Athina Christopoulou

General Hospital Of Patras St Andrews
Patra, ESYE23, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.

Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG study.

Journal: Cancer treatment and research communications

Published: March 17, 2026

Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.

Feasibility and impact of Lynch syndrome genetic testing in newly diagnosed colorectal cancer patients: a multicenter observational study in Greece.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study.

SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study.

Journal: JCO clinical cancer informatics

Published: February 03, 2026

Understanding exceptional response: The role of MINDY1 SNP in CDK4/6 inhibitor therapy for ER+, HER2- advanced breast cancer.

Understanding exceptional response: The role of MINDY1 SNP in CDK4/6 inhibitor therapy for ER+, HER2- advanced breast cancer.

Journal: HGG advances

Published: August 12, 2025

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

Journal: BMC cancer

Published: June 13, 2025

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study.

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study.

Journal: Cancers

Published: June 06, 2025

Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study.

Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 11, 2025

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study.

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study.

Journal: ESMO real world data and digital oncology

Published: January 04, 2025

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Journal: Future oncology (London, England)

Published: October 21, 2024

Molecular Alterations in Paired Epithelial Ovarian Tumors in Patients Treated with Neoadjuvant Chemotherapy.

Molecular Alterations in Paired Epithelial Ovarian Tumors in Patients Treated with Neoadjuvant Chemotherapy.

Journal: Cancers

Published: September 05, 2024

Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer.

Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer.

Journal: ESMO gastrointestinal oncology

Published: July 10, 2024

Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.

Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.

Journal: Diagnostics (Basel, Switzerland)

Published: June 11, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026